Accessibility Menu
Numinus Wellness logo

Numinus Wellness(OTC) NUMIF

Market Cap$9.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-96%
5 Year-96%
1 Year+23%
1 Month+24%
$0.04
+13.64%
+0.00Today
Numinus Wellness last closing stock price
MetricPriceDate
Last closeUSD 0.032026-07-31
Numinus Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-23%USD 0.042026-07-24
1 month+23.94%USD 0.022026-07-01
3 month+23.2%USD 0.032026-05-01
Year to date+2.67%USD 0.032025-12-31
1 year+23.2%USD 0.032025-07-31
3 year-80.79%USD 0.162023-08-01
5 year-96.04%USD 0.782021-07-30
Since inception-95.74%USD 0.722020-05-20

Numinus Wellness Financials at a Glance

Market Cap

$9.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-CA$4.47M

Net Income (TTM)

-CA$14.60M

EPS (TTM)

$0.00

P/E Ratio

-0.43

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$0.04

Volume

13,550

Open

$0.02

Previous Close

$0.04

Daily Range

$0.02 - $0.04

52-Week Range

$0.01 - $0.06

Estimated Earnings Date

Jul 31, 2026

NUMIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Numinus Wellness

Numinus Wellness Inc. is a pioneering company focused on psychedelic-assisted psychotherapy, aiming to transform the mental healthcare landscape. The organization operates through two main divisions: Salvation Botanicals, which provides laboratory services for psychedelics, and Numinus Health, which offers a range of therapeutic services.

Products and Services
  • Salvation Botanicals offers cultivation and analytical testing for psychedelics
  • Numinus Health provides psychotherapy, counselling, and neurofeedback services
  • Training and operational resources for practitioners in mental health
Growth Outlook
  • Increasing demand for mental health solutions drives potential market growth
  • Expansion of services aligns with evolving healthcare regulations
  • Strategic partnerships may enhance service delivery and reach
Financial Highlights
  • Recent quarterly revenue of CAD 1,802,942 shows growth potential
  • Gross profit margin improved to 48.26% in the latest quarter
  • Cash and cash equivalents increased to CAD 822,835, indicating liquidity
Numinus Wellness Inc. is positioned at the forefront of a rapidly evolving sector, with a focus on innovative therapeutic solutions. The company's dual approach, combining laboratory services and direct mental health support, allows for a comprehensive strategy in addressing mental health challenges. Recent financial performance indicates a positive trajectory, with notable revenue growth and improved gross profit margins. The increasing demand for mental health services, coupled with potential regulatory changes, presents significant opportunities for expansion. As the company continues to develop its offerings and strengthen its market presence, it remains an intriguing option for those interested in the intersection of healthcare and innovative therapies.
AI Generated • Jul 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

35

CEO

Michael Tan, MBA

Website

numinus.com

Headquarters

Vancouver, BC V6B 1R4, CA

NUMIF Financials

Key Financial Metrics (TTM)

Gross Margin

41.47%

Operating Margin

-75.23%

Net Income Margin

-297.88%

Return on Equity

833.04%

Return on Capital

-424.36%

Return on Assets

-230.35%

Earnings Yield

-2.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

320.55M

Volume

13.55K

Avg. Volume

118.82K

Financials (TTM)

Gross Profit

-CA$820.00K

Operating Income

-CA$23.21M

EBITDA

-CA$11.32M

Operating Cash Flow

-CA$9.59M

Capital Expenditure

-CA$154.18K

Free Cash Flow

-CA$9.75M

Cash & ST Invst.

CA$822.84K

Total Debt

CA$2.32M

Numinus Wellness Performance Analysis

Numinus Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-08-31CAD 1,192,541N/A
20222022-08-31CAD 5,105,143328.1%
20232023-08-31CAD 2,786,678-45.4%
20242024-08-31CAD 3,063,4319.9%
Numinus Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-08-31-325.4%
Q12024-11-30120.5%
Q22025-02-28-24.9%
Q32025-05-3119.2%
Numinus Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-08-31CAD -0.09N/A
20222022-08-31CAD -0.1681.6%
20232023-08-31CAD -0.09-47.7%
20242024-08-31CAD -0.05-42.6%
Numinus Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-08-3144.9%
Q12024-11-3065.5%
Q22025-02-28-680.5%
Q32025-05-3192.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

CA$1.80M

-58.5%

Gross Profit

CA$870.10K

-9.2%

Gross Margin

48.26%

N/A

Market Cap

$9.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$49.37K

N/A

Employees

200

N/A

Net Income

-CA$711.19K

+87.6%

EBITDA

-CA$601.02K

+86.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

CA$822.84K

-77.8%

Total Debt

CA$2.32M

-67.2%

Accounts Receivable

CA$1.42M

-16.9%

Inventory

CA$0.00

N/A

Long Term Debt

CA$1.73M

-60.7%

Short Term Debt

CA$589.42K

-77.8%

Return on Assets

-2.30%

N/A

Return on Invested Capital

-13.89%

N/A

Free Cash Flow

CA$392.99K

+111.3%

Operating Cash Flow

CA$390.09K

+111.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FPCGAvem Health Partners, Inc.
$1,025.00+0.00%
LUFFFHerbal Dispatch Inc.
$0.03+26.73%
ALRTFALR Technologies Inc.
$0.02+0.00%
PBSVPharma-Bio Serv, Inc.
$0.58+38.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About NUMIF

What is the current price of Numinus Wellness?

Numinus Wellness is trading at $0.04 per share.

What is the 52-week range for Numinus Wellness?

Over the past 52 weeks, Numinus Wellness has traded between $0.01 and $0.06.

How much debt does Numinus Wellness have?

As of the most recent reporting period, Numinus Wellness reported total debt of CA$1.69M.

How much cash does Numinus Wellness have on hand?

Numinus Wellness reported CA$598.45K in cash and cash equivalents in its most recent financial results.

What is Numinus Wellness’s dividend yield?

Numinus Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services